Yorkregion
Published September 23, 2026 · Updated September 24, 2026
Psyence BioMed Announces Strategic Ibogaine Investment - York Region
Read the full story at Yorkregion
The Company is actively advancing plans for a potential ibogaine clinical trial in Texas for Opioid Use Disorder (OUD). Texas Ibogaine Research.
Surfaced by 2 Google Alerts
- Ibogaine
- Psychedelic biotech
